(Q54660266)

2 June 2018

title

Achieving 95% cross-methodological concordance in HER2 testing: causes and implications of discordant cases. (English)

1 reference

2 June 2018

author name string

Erin E Grimm

1

1 reference

2 June 2018

Rodney A Schmidt

2

1 reference

2 June 2018

Paul E Swanson

3

1 reference

2 June 2018

Suzanne M Dintzis

4

1 reference

2 June 2018

Kimberly H Allison

5

1 reference

2 June 2018

American Journal of Clinical Pathology

language of work or name

English

1 reference

inferred from

publication date

1 August 2010

1 reference

2 June 2018

American Journal of Clinical Pathology

published in

1 reference

2 June 2018

volume

134

1 reference

2 June 2018

issue

2

1 reference

2 June 2018

page(s)

284-292

1 reference

2 June 2018

HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues

cites work

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

HER-2 testing in breast cancer using parallel tissue-based methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

Evaluating HER2 amplification and overexpression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPUQB18XZOHHBJ

21 January 2018

Identifiers

DOI

10.1309/AJCPUQB18XZOHHBJ

1 reference

2 June 2018

1 reference

2 June 2018